Title
Category
Credits
Event date
Cost
  • CME Activities
  • Critical Care
  • Emergency
  • Neurology
  • Nursing Continuing Education
  • Stroke
  • Tenecteplase
  • Thrombolytics
  • Nursing Education Hours
  • Participation
$0.00
Intravenous thrombolytics is the mainstay of acute therapy in ischemic stroke.  While alteplase has been FDA-approved for this indication since the 1990s, Tenecteplase has recently gained traction for usage in acute ischemic stroke treatment as well.  This lecture summarizes the existing evidence and practical considerations for use of Tenecteplase in stroke therapy.